What new treatments for HER2-Positive Breast Cancer are being developed in 2026

Her__positive_breast_cancerMay 23, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

New HER2-Positive Breast Cancer Treatments in Development

I appreciate your question about emerging treatments for HER2-positive breast cancer. However, I need to be transparent about what I can tell you based on current evidence.

What I Can Share

The medical guidelines and resources available to me don't contain specific information about HER2-positive breast cancer treatments in development for 2026. This is partly because:

Treatment development moves quickly - New drugs and combinations are constantly being studied, and what's in development today may change significantly by 2026
My sources have limitations - While I have access to educational webinars and current guidelines, they don't include detailed pipelines of future treatments

What IS Currently Standard for HER2-Positive Breast Cancer

According to NCCN (National Comprehensive Cancer Network) Guidelines, current HER2-positive breast cancer treatment typically includes:

HER2-targeted therapies like trastuzumab (Herceptin) and pertuzumab (Perjeta)
Tyrosine kinase inhibitors like lapatinib and tucatinib
Antibody-drug conjugates like T-DM1 (Kadcyla) and fam-trastuzumab deruxtecan (Enhertu)
Combinations of these with chemotherapy or hormone therapy depending on stage and receptor status

Where to Find Information About Emerging Treatments

For the most current information about treatments in development:

ClinicalTrials.gov - Search for "HER2-positive breast cancer" to see active clinical trials
ASCO (American Society of Clinical Oncology) - Publishes annual updates on emerging therapies
American Cancer Society - Maintains current treatment information
Your oncologist - Can discuss what's on the horizon for your specific situation

Questions to Ask Your Care Team

Are there any new HER2-targeted therapies in clinical trials that might be appropriate for my specific case?
What emerging treatment combinations are showing promise in recent studies?
Should I consider participating in a clinical trial for a newer HER2-directed therapy?
How do you stay updated on new treatment developments for HER2-positive breast cancer?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →